Acta Med. 2017, 60: 82-84

https://doi.org/10.14712/18059694.2017.98

Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia

Francisco José Fernández-Fernándeza, Eugenia Ameneiros-Lagoa, Cintia Tuñas-Gestob, Inmaculada Gómez-Buelaa

aDepartment of Internal Medicine, Complejo Hospitalario Universitario de Ferrol, Ferrol 15405, Spain
bSection of Neurology, Complejo Hospitalario Universitario de Ferrol, Ferrol 15405, Spain

Received March 30, 2017
Accepted May 23, 2017

References

1. Rinder HM, Tracey JB, Recht M, et al. Differences in platelet alpha- granule release between normals and immune thrombocytopenic patients and between young and old platelets. Thromb Haemost 1998; 80: 457–62.
2. Fernández-Fernández FJ. Acute coronary syndrome in patients with thrombocytopenia. Rev Esp Cardiol (Engl Ed.) 2017; 70: 682. <https://doi.org/10.1016/j.recesp.2017.02.029>
3. Manoharan A, Brighton T, Gemmell R, Lopez K, Moran S, Kyle P. Platelet dysfunction in myelodysplastic syndromes: a clinicopathological study. Int J Hematol 2002; 76: 272–8. <https://doi.org/10.1007/BF02982798>
4. Kantarjian H, Giles F, List A, et al. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer 2007; 109: 1705–14. <https://doi.org/10.1002/cncr.22602>
5. Nachtkamp K, Stark R, Strupp C, et al. Causes of death in 2877 patients with myelodysplastic syndromes. Ann Hematol 2016; 95: 937–44. <https://doi.org/10.1007/s00277-016-2649-3>
6. Steensma DP. Myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc 2015; 90: 969–83. <https://doi.org/10.1016/j.mayocp.2015.04.001>
7. Fruchter O, Blich M, Jacob G. Fatal acute myocardial infarction during severe thrombocytopenia in a patient with idiopathic thrombocytopenic purpura. Am J Med Sci 2002; 323: 279–80. <https://doi.org/10.1097/00000441-200205000-00010>
8. Hasper D, Schrage D, Niesporek S, Knollmann F, Barckow D, Oppert M. Extensive coronary thrombosis in thrombotic-thrombocytopenic purpura. Int J Cardiol 2006; 106: 407–9. <https://doi.org/10.1016/j.ijcard.2004.12.095>
9. Bermejo N, Sigüenza R, Ibáñez F. Management of primary immune thrombocytopenia with eltrombopag in a patient with recent acute coronary syndrome. Rev Esp Cardiol (Engl Ed) 2017; 70: 56–7. <https://doi.org/10.1016/j.recesp.2016.06.016>
10. Feher A, Kampaktsis PN, Parameswaran R, Stein EM, Steingart R, Gupta D. Aspirin is associated with improved survival in severely thrombocytopenic cancer patients with acute myocardial infarction. Oncologist 2017; 22: 213–21. <https://doi.org/10.1634/theoncologist.2016-0110> <PubMed>
11. Sarkiss MG, Yusuf SW, Warneke CL, et al. Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer 2007; 109: 621–7. <https://doi.org/10.1002/cncr.22434>
12. Gupta R, Soupir CP, Johari V, Hasserjian RP. Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation. Br J Haematol 2007; 139: 265–8. <https://doi.org/10.1111/j.1365-2141.2007.06776.x>
13. Fernández-Sojo J, Vives S, Oliveras Vilà T, Ribera JM. Exudative pericardial effusion and oligoarthritis in a patient newly diagnosed with myelodysplastic syndrome. Med Clin (Barc) 2014; 143: 43–4. <https://doi.org/10.1016/j.medcli.2013.09.009>
14. Choi J-H, Ahn M-J, Park Y-W, Oh HS, Lee YY, Kim IS. A case of erythema nodosum and serositis associated with myelodysplastic syndrome. Korean J Intern Med 2005; 20: 177–9. <https://doi.org/10.3904/kjim.2005.20.2.177> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive